Results 21 to 30 of about 42 (41)
Рациональная фармакотерапия в кардиологии, 2015 Data on the problem of thromboembolic complications in non-valvular atrial fibrillation are presented. Peculiarities of anticoagulant therapy to prevent thromboembolic complications, the difficulties in drug choice and dosage adjustment are also ...
E. L. Dolgova +2 more
doaj +1 more source
Acta Biomedica ScientificaBackground. The use of P-glycoprotein (P-gp) inhibitors and carriage of certain ABCB1 polymorphisms can lead to increased concentrations of rivaroxaban and the development of bleeding.The aim of the study. To study the features of drug-drug interactions (
D. A. Sychev +9 more
doaj +1 more source
RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION
Рациональная фармакотерапия в кардиологии, 2015 The possibilities of antithrombotic therapy in atrial fibrillation are highlighted. The alternative antithrombotic agents, including rivaroxaban presented along with the traditional drugs (acetyl-salicylic acid, warfarin).
M. Yu. Gilyarov
doaj +1 more source
COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS
Рациональная фармакотерапия в кардиологии, 2015 Indirect comparisons of new oral anticoagulants are performed with focus on their safety. Apixaban, an oral inhibitor of Xa factor, nowadays can be considered as a drug with very good safety profile according to randomized trials results and performed ...
V. A. Sulimov +2 more
doaj +1 more source
The problem of choosing an anticoagulant for stroke prevention in patients with atrial fibrillation
Медицинский совет, 2014 The article is a literature review on the problem of thromboembolic complications in non-valvular atrial fibrillation, the peculiarities of anticoagulant therapy and challenges associated with the selection of drugs for stroke prevention.
EL Dolgova, IM Sokolov, YG Schwarz
doaj +1 more source
Pulmonary embolism: inpatient and outpatient treatment
Медицинский совет, 2014 Pulmonary embolism (PE) is a rather common emergency situation. Occlusion of pulmonary arteries of different calibre may result in critical condition, shock, sudden death, while in a number of patients who survived thromboembolism it may lead to long ...
GE Gendlin +3 more
doaj +1 more source
Venous thromboembolism - Expanding therapeutic options
Медицинский совет, 2013 Venous thromboembolism (VTE) is caused by the formation of blood clots within a vein resulting in vein occlusion and risk of blood clots travelling to the pulmonary arteries.
I. A. Filippova
doaj +1 more source
Медицинский совет, 2014 Cost reduction associated with the use of rivaroxaban compared with the enoxaparin + warfarin combination for for deep vein thrombosis and pulmonary thromboembolism when treated in the inpatient setting.
MV Avksentyeva, OV Shatalova
doaj +1 more source
СОВРЕМЕННЫЙ ПОДХОД В ЛЕЧЕНИИ ОСТРОГО ТРОМБОЗА ГЛУБОКИХ ВЕН ПРЕПАРАТОМ РИВАРОКСАБАН
Архивъ внутренней медицины, 2015 Aim of prospective clinical study was to evaluate effectiveness, safety and convenience of treatment deep vein thrombosis with oral anticoagulant — Rivaroxaban from the 1st day of treatment.
Е. П. Кривощеко в +1 more
doaj +1 more source
Медицинский совет, 2013 The article tells about the study of use of semiconstrained endoprosthesis constructions at primary replacement of knee joint; treatment methods, main advantages of semiconstrained endoprosthesis for knee joint and rehabilitation.
A. A. Kardanov +4 more
doaj +1 more source